Approach | Types of stakeholders | |||||||||||||
Governments/ policy-makers | Healthcare providers | Researchers/ academia | Members of the public | Patients and their representatives | Caregivers | Health system payers | Healthcare managers | Intergovernmental agencies/ Research funders | Product makers/Industry | Press and media organisations | NGOs and advocacy groups | Internal staff | Other | |
% of approaches reporting* | n=10 45% | n=16 73% | n=17 77% | n=9 41% | n=13 59% | n=7 32% | n=4 24% | n=2 9% | n=6 27% | n=3 18% | n=1 6% | n=8 36% | n=3 18% | n=6 27% |
Abma, 201050 | ✓ | ✓ | ✓ | ✓ | ||||||||||
Ball, 201664 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||
Bennett, 2010; Bennett, 2012; Saldanha, 201341–43 | ✓ | ✓ | ✓ | ✓ | ||||||||||
Berra, 201059 | ✓ | ✓ | ||||||||||||
Chang, 201260 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||
Chapman, 201365 | ✓ | ✓ | ✓ | ✓ | ||||||||||
Okello, 2000; Lansang 199739 40 | ✓ | ✓* | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||
Cowan, 201345 | ✓* | ✓ | ✓ | ✓ | ✓ | |||||||||
Dubois, 201161 | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||
Edwards, 2019 (52) | ✓ | ✓ | ✓ | |||||||||||
Franck, 2018; Franck, 2020 49 56 | ✓ | ✓ | ||||||||||||
Ghaffar, 2009; 200938 48 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||
Kapiriri, 201863 | ✓ | ✓ | ||||||||||||
Lomas, 200346 | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||
Montorzi, 201047 | ✓** | |||||||||||||
NIH, 200157 | ✓ | ✓† | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||
Pratt, 201655 | ✓ | ✓ | ||||||||||||
Rudan, 200837 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||
Somanadhan, 202053 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||
Viergever, 201062 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||
Wald, 201451 | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||
Yan, 202054 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
*The denominator reflects the total number of approaches that proposed stakeholder involvement as part of the priority setting.
†Includes professional associations.